About
MGI Tech is a leading biotechnology company specializing in next-generation sequencing (NGS), multi-omics technologies, and laboratory automation for the global life sciences and healthcare industries. Founded over a decade ago, MGI has built a comprehensive ecosystem of genomic tools used by researchers, clinicians, and diagnostic laboratories worldwide. At the core of MGI's offering is its proprietary DNBSEQ sequencing technology, which delivers high-precision, cost-effective sequencing across a range of throughput needs. The company's sequencer lineup—branded SEQ All—caters to applications from rapid clinical turnaround to high-volume population genomics. MGI's Generative Lab Intelligence (GLI) platform brings AI-driven automation and data intelligence to laboratory workflows, enabling smarter sample processing, QC, and sequencing decisions. Their multi-omics portfolio includes spatial transcriptomics (Stereo-seq), spatial proteomics (VisiOmics), and fluorescence-based imaging systems. The PrepALL system provides precision automation for sample preparation, reducing manual errors and increasing throughput. MGI also supports end-to-end workflows from collection and storage through library preparation, sequencing, and data processing. MGI Tech is used across academic research institutions, hospitals, biotech companies, and public health programs globally. Certified under ISO 13485, ISO 14001, and ISO 27001, the company upholds the highest standards in medical device quality, environmental management, and information security.
Key Features
- DNBSEQ Sequencing Technology: Proprietary high-precision, cost-effective sequencing platforms (SEQ All lineup) covering a broad range of throughput and application needs from clinical diagnostics to large-scale genomics.
- Generative Lab Intelligence (GLI): AI-powered platform that automates lab workflows, enhances QC decisions, and brings intelligent data processing to sequencing operations.
- Multi-Omics Solutions: Integrated spatial transcriptomics (Stereo-seq), spatial proteomics (VisiOmics), and fluorescence imaging tools enabling comprehensive biological discovery across genomic dimensions.
- PrepALL Lab Automation: Precision robotic sample preparation system that reduces manual handling, improves reproducibility, and scales throughput for high-volume sequencing workflows.
- End-to-End Genomic Workflow: Full workflow support from sample collection and storage through library preparation, sequencing, and downstream data processing under one integrated ecosystem.
Use Cases
- Large-scale population genomics and whole-genome sequencing studies requiring high-throughput, cost-effective sequencing platforms.
- Clinical diagnostics and precision medicine applications where accurate, rapid sequencing informs patient treatment decisions.
- Spatial transcriptomics and proteomics research to map gene and protein expression within tissue samples at single-cell resolution.
- Microbiome research and metagenomics projects, including large-scale initiatives like the Million Microbiome of Humans Project.
- Drug discovery and biomarker identification workflows leveraging AI-assisted data processing and multi-omics integration.
Pros
- Comprehensive Genomics Ecosystem: MGI offers a tightly integrated suite covering sequencing hardware, AI lab intelligence, multi-omics, and automation—reducing the need for third-party vendors.
- Proven Global Reach: With 3,560+ users across six continents and partnerships with top universities and hospitals, MGI has demonstrated broad real-world validation of its platforms.
- AI-Enhanced Workflows: The GLI platform brings generative AI into lab operations, enabling smarter, faster decisions across sequencing and sample processing.
- Strong Regulatory Certifications: ISO 13485, ISO 14001, and ISO 27001 certifications ensure compliance with medical device quality, environmental, and data security standards.
Cons
- Enterprise and Institutional Focus: MGI's products are primarily designed for research labs, hospitals, and large biotech firms, making them inaccessible or cost-prohibitive for smaller teams or individual researchers.
- Hardware Dependency: The platform's full capabilities require proprietary MGI sequencing hardware, limiting flexibility for labs already invested in competing sequencer ecosystems.
- Limited Self-Service Information: Pricing, detailed technical specs, and procurement information are not publicly listed, requiring direct engagement with sales for evaluation.
Frequently Asked Questions
What is MGI Tech?
MGI Tech is a global biotechnology company that develops and manufactures genomic sequencing platforms, multi-omics solutions, and AI-powered lab automation tools for life sciences, healthcare, and diagnostics applications.
What is DNBSEQ technology?
DNBSEQ is MGI's proprietary sequencing technology based on DNA nanoballs (DNBs). It delivers high-accuracy sequencing with reduced error propagation compared to some competing methods, and is available across multiple throughput tiers in MGI's sequencer lineup.
What is Generative Lab Intelligence (GLI)?
GLI is MGI's AI-powered platform designed to bring generative intelligence into laboratory workflows. It automates decision-making, quality control, and data processing across sequencing operations to improve speed and reproducibility.
What multi-omics tools does MGI offer?
MGI offers Stereo-seq for spatial transcriptomics, VisiOmics for spatial proteomics imaging, and FluoXpert for fluorescence-based analysis—enabling researchers to study gene expression, protein distribution, and cellular interactions at spatial resolution.
Who are MGI Tech's products designed for?
MGI's products are designed for academic research institutions, hospitals, clinical genomics labs, pharmaceutical and biotech companies, and public health programs conducting large-scale genomic or multi-omics studies.
